Analytics

Analysts: Amarin poised for huge gains if Vascepa trial comes back positive

Analysts: Amarin poised for huge gains if Vascepa trial comes back positive

By

Analysts from Jefferies predicted up to $2 billion in peak sales if Amarin's seven-year trial data is positive.

Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug

Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug

By

Sun Pharma's branded prostate cancer treatment Yonsa just received FDA approval.

Heather Bell, Sanofi

Heather Bell, Sanofi

Heather Bell is SVP, global head of digital and analytics of Sanofi.

Can the healthcare industry really expect to drive patient engagement?

Can the healthcare industry really expect to drive patient engagement?

Increasing patient engagement as a tool for improving care and outcomes has been a tough code to crack for the healthcare industry.

Edelman health veteran Donna Duncan joins W2O Chicago

Edelman health veteran Donna Duncan joins W2O Chicago

By

W2O's Windy City office has added three health and analytics leaders over the past six months.

Speaker bureaus must change to stay relevant, experts say

Speaker bureaus must change to stay relevant, experts say

By

To remain relevant, speakers bureaus must evolve to a strategic marketing tactic with personalized messaging to the customer.